| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |